STRESAM

This brand name is authorized in France, Malta, South Africa, Tunisia.

Active ingredients

The drug STRESAM contains one active pharmaceutical ingredient (API):

1	Etifoxine UNII NBL8010WH5 - ETIFOXINE HYDROCHLORIDE
	Etifoxine is a nonbenzodiazepine anxiolytic agent and acts as a GABAA receptor positive allosteric modulator and as a ligand for translocator proteins. Both mechanisms are conjectured to contribute to its anxiolytic properties. Etifoxine primarily indicated for short-term management of adjustment disorder, specifically instances of situational depression accompanied by anxiety, such as stress-induced anxiety.
	Read more about Etifoxine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
STRESAM Capsule	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N05BX03	Etifoxine	N Nervous system → N05 Psycholeptics → N05B Anxiolytics → N05BX Other anxiolytics
Discover more medicines within N05BX03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
FR	Base de données publique des médicaments	63136857
MT	Medicines Authority	MA239/00401
TN	Direction de la Pharmacie et du Médicament	5193021
ZA	Health Products Regulatory Authority	A39/2.6/0072